Is Moderna's Stock Price Ridiculously Expensive Right Now?
A hot stock can heat up to the point that its sizzle fizzles. Some investors are wondering if that fate is in store for Moderna (NASDAQ: MRNA).
Excitement about Moderna's COVID-19 vaccine candidate, mRNA-1273, has steadily climbed throughout 2020. As a result, the biotech stock has skyrocketed close to 650% year to date. Is Moderna's stock price ridiculously expensive right now?
Image source: Getty Images.
Source Fool.com